AKT1 and leukemia: Thus, such a cross-regulation between PI3K/Akt and GSK-3 isoforms appears to be a common mechanism underlying the regulation of NK cell reactivity against leukemia cells according to the context (i.e., activating ligand expression vs. NK cell function).